Poster Tours
Digital Poster screens are located in Hall 3
Guided Poster Tours take place as follows:
Poster Session 1: Wed 6, 1145
Screen 1: Epilepsy
Screen 2: Headache
Screen 3: MS/Inflammatory
Screen 4: Muscle / NMJ / Peripheral Nerve
Screen 5: Movement Disorders
Poster Session 2: Thur 7, 1230
Screen 6: Cognitive
Screen 7: Vascular
Screen 8: Acute Neurology / Oncology
Screen 9: QST
Screen 10: Infection/Encephalitis/Functional
Wed 6 May • 1145 - 1245
Screen 1: Epilepsy
1 Sarah Wrigley: Cryptogenic New Onset Refractory Status Epilepticus in an adult: Clinical pearls and pitfalls of management
2 Hannah Eaton: Patients who do not attend their appointment for assessment after a first suspected seizure
3 Vivienne Evans: Diagnostic Value and Utilisation of Home Video in Epilepsy Care Within a Tertiary Neurology Department
4 Sam Amin: Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results From a Phase 3 Study
5 Kabir Josan: Attendance rates for epilepsy appointments in relation to deprivation: comparison of face-to-face and virtual appointments.
6 William Clark: Vagus nerve stimulation induced reflex seizures
7 Aidan Whitehead: Occipital Lobe Status Epilepticus Secondary to Non-Ketotic Hyperglycaemia
8 Emily Pegg: An Audit of Women’s Health Counselling in the Epilepsy Clinic
9 Alexander Grundmann: The Public Health and Economic impact of SUDEP: A Hamiltonian Markov Chain Monte Carlo Model
10 Lavindren Luke Panneerchelvam: Newcastle’s First Experience With EASEE® Epicranial Neuromodulation For Drug-Refractory Focal Epilepsy: A Two-Patient Case Series.
Screen 2: Headache
11 Dwij Mehta: Evaluating the role of non-targeted epidural blood patch in the management of spontaneous intracranial hypotension.
12 Stephanie Williams: Intracranial Hypertension – A clinical pearl in consulting haematology patients
14 Amy Mardle: Perinatal use of corticosteroid containing greater occipital nerve injections for primary headache disorders
15 Benjamin Edmans: Unusual Headache Case Reports: On the potential aetiologies of Hypnogogic and Shower Headaches
16 Md Tariqul Islam: Intracranial Hypertension Likely Secondary to Testosterone Intake in a Patient Undergoing Female-to-Male Transition
17 Richard Oguntoye: Secondary Headaches Due to Dural Arteriovenous Fistulas: A Mimic of Cluster Headache
18 Andreas Yiangou: Identifying microRNA markers in idiopathic intracranial hypertension: a pilot study.
19 Rudramun Gopal: Trigeminal Neuralgia as the Sentinel Presentation of Chiari I–Related Syringomyelia in an Adolescent
20 Dwij Mehta: Evaluating the prevalence and characteristics of orthostatic headaches in postural tachycardia syndrome
Screen 3: MS/Inflammatory
21 Gavin Giovannoni: Ocrelizumab vs placebo in PPMS: efficacy and safety results of the Phase IIIb ORATORIO-HAND study
22 Sean Apap Mangion: Baseline Patient-Reported Outcomes Predict Clinical Progression in Progressive MS: An MS-SMART Post-Hoc Analysis
23 Ashraf Hunedy: Recurrent Area Postrema Syndrome in a Suspected Seronegative NMOSD: An 18-Year Follow-Up Case
24 Prateek Choudhary: SHIELD: Surveillance of health and infections in MS linked to disease modifying therapies
25 Piri Ananthavarathan: Changes in pre-lesional normal-appearing white matter are detectable 16 years before lesion formation in MS
26 Dashne Omar: A Scoping Review of Neurosarcoidosis: The changing treatment land-scape and its clinical determinants.
27 Rajesh Ambati: From Auricular Inflammation to Myelitis: The Neurological Spectrum of Relapsing Polychondritis
28 Aneliya Takova: First presentation with Optic neuritis does not result in delayed DMT initiation in MS
29 Michelle Richardson: Acute Cerebellitis Following Semaglutide Use
30 Edward Nicholas: Switching to biosimilars in multiple sclerosis: patient experiences on natalizumab
Screen 4: Muscle / NMJ / Peripheral Nerve
31 Rajesh Ambati: A Myositic Mirage: When Rheumatoid Vasculitis Mimics Inflammatory Myopathy
32 Bhairavi Wijayendran: Myasthenia Gravis in Pregnancy: Outcomes from a Tertiary Centre Cohort
33 Viva Levee: Establishing a Tofersen service for SOD1-ALS:Audit of single centre experience at St Georges Hospital, London
34 Murva Asad: Progressive muscle MRI changes in periodic paralysis: a longitudinal cohort study
35 Rebecca Cooper: Acquired Multiple Acyl CoA Deficiency: 2 case reports
36 Lucy Manley: NF2-Schwannomatosis Associated Polyneuropathy: A Single Retro-spective Case Series
37 Li Ying Tay: Monomelic weakness and numbness: A case of radiotherapy-induced Focal CIDP
38 Michael Lunn: Acquired Vitamin B6 Deficiency in POEMS: A Marker of
Disease Activity and Cause of Neuropathy?
39 Devan Mair: From IVIg Optimisation to Home-Based Immunoglobulin Therapy
40 Muhammed Ameen Noushad: Optimising CIDP Care: A systematic review of the evidence supporting structured Immunoglobulin withdrawal trials
Screen 5: Movement Disorders
41 Ashmit Bhardwaj: Revisiting Laterality in Drug-Induced Parkinsonism: Challenging the Symmetry Paradigm in a 10-Year Tertiary Cohort
42 Kinan Muhammed: Real-World Multicentre Smartphone Based Tracking for Parkinson’s Disease
43 Julia Greenland: Sex-dependent differences in the immune response to treatment with azathioprine in Parkinson’s disease
44 Akshayaa Kumar Aggarawal: Atypical Anatomy, Classic Movements: Hemichorea–Hemiballismus from Centrum Semiovale Infarct
45 Viveka Biswas: Spino-cerebellar ataxia 27B with multi-system atrophy-like presenta-tion
46 Lucas Koolen: The Effect of Foslevodopa/Foscarbidopa Treatment on Nonmotor Symptom Burden in Advanced Parkinson’s Disease
47 Paola Giunti: Omaveloxolone in Friedreich Ataxia: 4-Year Efficacy and Safety Data From MOXIe Extension
48 Vanessa Ng: Investigating Motion Capture Movement Metrics for Disease Progression Biomarkers in Progressive Supranuclear Palsy patients.
49 Lucas Koolen: Heat Map Visualisation of Motor States in People with Parkinson’s Disease Treated with Foscarbidopa/Foslevodopa
50 Jacob Mistry: Dual pathology in late-onset episodic ataxia: SCA27B with co-existing parkinsonian degeneration
Thur 7 May • 1230 - 1330
Screen 6: Cognitive
51 Michael Rushworth: A 48-Month Analysis of the Lecanemab Clarity AD Open-Label Extension in APOE4 Non-Carriers and Heterozygotes
52 Zhilin Jiang: Autonomic involvement across the spectrum of genetic prion diseases
53 John Erskien: Neurodegenerative outcomes in antidepressant-associated REM sleep behaviour disorder
54 Arthur Stacey: Validating Referral Triage Criteria for Functional Cognitive Symptoms in a Cognitive Neurology Clinic
55 Anastasia Mirza-Davies: Night-time activity detected by contactless remote monitor-ing is associated with falls in dementia
56 Sanjida Chowdhury: When the Past Catches Up: Iatrogenic Creutzfeldt–Jakob Dis-ease With a 39-Year Incubation Period
57 Ben Jacobs: The contribution of Apoliproprotein E genetic variation to dementia risk in British South Asians
58 Rebecca Kuruvilla: A Real-World UK Experience of Disease-Modifying Therapy in Alz-heimer’s Disease
59 Hin Kwan Jeroan Yip: Validating a Clinical Assessment of Working Allocentric Spatial Memory
60 Charlie Nye: Relationships between sleep actigraphy, subjective sleep, fatigue, and cognition in older adults in Northern Tanzania
Screen 7: Vascular
61 Rohan Palathinkal: A case of Moyamoya syndrome associated with Grave’s disease
62 Swetha Giridharan Menon: Challenging case of Bilateral Opercular syndrome
63 Amit Chowdhury: Enhancing Secondary Stroke Prevention: An Audit at Derriford Hospital, Plymouth
64 Angela Yan: A rare (but treatable) cause of both ischaemic and haemorrhagic stroke in a young adulta
65 Lupei Cai: Multiple simultaneous acute infarcts as a presentation of CADASIL, and its association with recent infection
66 Sashini Mariathasan: What are we missing? A decade of auditory symptoms in the TIA clinic
67 Sashini Mariathasan: A Decade of Vestibular Presentations to TIA Service: A High-Risk Cerebrovascular Presentation
68 Obioma Orazulume: The Stroke Unit as a Portal for Primary Prevention: Screening At-Risk Relatives
69 Ariel George: Immune effector cell-associated neurotoxicity syndrome (ICANS) with intracerebral haemorrhage – a case report.
70 Molly Yeo: Striking clinico-radiological dissociation in hypertensive brainstem en-cephalopathy complicated by delayed brainstem haemorrhage
Screen 8: Acute / Oncology
71 Linda Lei: Rapid Deterioration on ITU: A Devastating Combination of Genetics and a Viral Infection
72 Musab Eltahir: Labrune syndrome without cysts: a genetically confirmed case highlighting diagnostic challenges.
73 Aiknaath Jain: Delayed Post-Hypoxic Leukoencephalopathy after Overdose: A Case of Biphasic Neurologic Decline with Unexpected Recovery
74 Niamh Oldfield: Increasing use of immune-checkpoint inhibitors: need for increased awareness, and implications for service development
75 Sabbiha Majumder: A rare cause of bilateral arm weakness in an older adult
76 Vaishnavi Sharma: Development and Validation of the NOVA Score for Surgical Triage in Metastatic Spinal Cord Compression
77 Vaishnavi Sharma: Human Versus Machine: Comparative Accuracy of Survival Prediction in Metastatic Spinal Cord Compression
78 Marie Ryan: Beyond Infection and Infiltration: Autoinflammatory Neurological Disease in Chronic Myelomonocytic Leukaemia
79 Mai Elrayes: Dysarthria and Dysphagia: When a Tongue Tumour Mimics Central Causes
80 Amelia Panavila: Gut Instinct: When Gastrointestinal Symptoms Signal a Neurologi-cal Storm
Screen 9: Quality, Service & Training
81 Teona Serafimova: Immunoglobulin G reduction with different plasma exchange regimes in autoimmune neurological conditions
82 Hollie Gibbins: Drop the ‘Drop Test’ for Lower Limb Tone: Assessing Inaccuracies in Internet Education
83 Swetha Giridharan Menon: Efficacy of Botox Injections for Refractory Trigeminal Neuralgia
84 Asha Bissessar: Development of an acute dizziness pathway for management of patients in Southwest London
85 Ashni Khetarpal: The challenges of acute neuro-ophthalmology presentations: Standardised pathways, early OCT and SDEC may be the answer
86 Anuriti Aojula: Utility of non-mydriatic fundus photography in same day emergency care (SDEC): a pilot study
87 Raluca Negulescu: Improving medical students’ knowledge and confidence in diagnosing Functional Neurological Disorders (FND)
88 Camille Carroll: Join Parkinson’s Research (JPR@Research+Me): A UK-wide registry to support clinical trial recruitment in Parkinson’s disease
89 Alex Hayes: Socioeconomic health inequalities in access to shunting for Normal Pressure Hydrocephalus at two regional centres
90 Georgia Ferguson: Focused Ultrasound Thalamotomy: Post-procedural Side Effect Profile from 4 years of Treatments in Scotland
Screen 10: Infection/Encephalitis/Functional
91 Yen Wen Phong: Extensive Spinal Subdural Collections in MSSA Meningitis: An Uncommon Cause of Acute Paraparesis
92 Jafor Sadeque: Diagnostic accuracy and management of encephalitis in a secondary care setting – a local audit
93 Kyaw Soe Thein: Diagnostic Convergence: Alpha-Enolase and Anti-TPO Antibodies in Autoimmune Encephalopathy
94 Michelle Richardson: Unmasking Late-Onset Rasmussen’s Encephalitis
95 Jack Tallentire: Functional Neurological Disorder (FND) in Primary Care: Survey of General Practitioners’ Knowledge, Attitudes and Practices
96 Owen Pickrell: Functional/Dissociative Seizures (FDS) in Wales, a retrospective study using routinely collected data
97 Andrew Jones: Altered postural control in PPPD: evidence for maladaptive mechanisms from motion capture posturography
98 Andrew Whitfield: Objective measurement of Hoover’s sign in healthy controls and patients with functional neurological disorder
99 Antoniette Marie Guerrero: Migraine prevalence and management in functional neurological disorder: a retrospective audit
100 Benjamin Sacks: A technique for inducing hoovers sign in healthy controls: mechanistic insights into functional neurological symptoms
Email the ABN
Email the Conference Team
abn@phproductionservices.co.uk
Call the ABN
44 (0) 20 7405 4060